Uremic Solutes Tied With Cardiovascular Death in Diabetic Kidney Disease
Investigators focused on the prognostic value of the uremic solutes asymmetric dimethylarginine, symmetric dimethylarginine, and trimethylamine-N-oxide.
All articles by Natasha Persaud
CKD-MBD Marker Changes Vary Across Dialysis Modalities
Use of home dialysis and modalities other than conventional in-center hemodialysis is expected to grow.
SGLT2 Inhibitors for Diabetes May Protect Against AKI, Increase UTI Risk
Providers need to assess the benefit-risk profile of SGLT2 inhibitors for individual patients, and take steps to avoid unnecessary risks.
Etelcalcetide Effective in Cases Where Cinacalcet Is Problematic
Switching from oral to intravenous calcimimetic may lower PTH levels in patients on hemodialysis with poor tolerance.
Physical Activity Reduces Cardiovascular Mortality in Hemodialysis Population
Even occasional physical activity was linked to a decreased risk for death from any cause, investigators reported.
Canagliflozin May Reduce Hyperkalemia Risk in Diabetes + CKD
Sodium-glucose cotransporter 2 (SGLT2) inhibitors provide cardiorenal protection and may lower the risk for hyperkalemia.
Race-Free GFR Equations Based on Creatinine Plus Cystatin C More Accurate
The current guideline-recommended creatinine-based eGFR equation incorporates a race coefficient that may overestimate eGFR in Black adults and contribute to discordant care.
Study IDs Possible Relationship Between NGAL and CKD-MBD in Dialysis
Neutrophil gelatinase-associated lipocalin (NGAL) is not only a biomarker of kidney injury but also a bone-derived factor involved in metabolism.
Metabolic Syndrome Ups Major Cardiovascular, Death Risks in CKD
Avoiding even 1 metabolic syndrome component might decrease the risk for a cardiovascular event or premature death, investigators suggest.
FDA OKs Third COVID-19 Vaccine Dose for Immunocompromised Patients
Here’s what clinicians and patients need to know.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...